Functional Evaluation and Characterization of a Newly Developed Silicone Oil-Free Prefillable Syringe System von Yoshino, Keisuke, Nakamura, Koji, Yamashita, Arisa, Abe, Yoshihiko, Iwasaki, Kazuhiro, Kanazawa, Yukie, Funatsu, Kaori, Yoshimoto, Tsuyoshi, Suzuki, Shigeru

Volltext

Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease von Kohjima, Motoyuki, Enjoji, Munechika, Higuchi, Nobito, Kato, Masaki, Kotoh, Kazuhiro, Yoshimoto, Tsuyoshi, Fujino, Tatsuya, Yada, Masayoshi, Yada, Ryoko, Harada, Naohiko, Takayanagi, Ryoichi, Nakamuta, Makoto

Volltext

Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma von Sugimoto, Rie, Motomura, Kenta, Ooho, Aritsune, Aratake, Yoshifusa, Ueda, Akihiro, Senju, Takeshi, Tanaka, Yuki, Yada, Masayoshi, Tanaka, Kohsuke, Kuwano, Akifumi, Morita, Yuusuke, Nagasawa, Shigehiro, Ooe, Mari, Mutsuki, Taiji, Yoshimoto, Tsuyoshi, Yamashita, Naoki, Nakashima, Mai, Hioki, Tomonobu, Koyanagi, Toshimasa, Higuchi, Nobito, Nakamura, Tsukasa, Harada, Shigeru, Tanaka, Masatake, Tada, Seiya, Satoh, Takeaki, Uchimura, Koutarou, Kuniyoshi, Masami, Nakamuta, Makoto, Kohjima, Motoyuki, Liver Disease Investigators' Network of Kyushu University & Surrounding Hospitals (LINKS)

Volltext

Genetic polymorphisms of OCT-1 confer susceptibility to severe progression of primary biliary cirrhosis in Japanese patients von Ohishi, Yuki, Nakamuta, Makoto, Ishikawa, Naoko, Saitoh, Ohki, Nakamura, Hitomi, Aiba, Yoshihiro, Komori, Atsumasa, Migita, Kiyoshi, Yatsuhashi, Hiroshi, Fukushima, Nobuyoshi, Kohjima, Motoyuki, Yoshimoto, Tsuyoshi, Fukuizumi, Kunitaka, Ishibashi, Makoto, Nishino, Takashi, Shirabe, Ken, Taketomi, Akinobu, Maehara, Yoshihiko, Ishibashi, Hiromi, Nakamura, Minoru

Volltext

Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver von Fujino, Tatsuya, Nakamuta, Makoto, Yada, Ryoko, Aoyagi, Yoko, Yasutake, Kenichiro, Kohjima, Motoyuki, Fukuizumi, Kunitaka, Yoshimoto, Tsuyoshi, Harada, Naohiko, Yada, Masayoshi, Kato, Masaki, Kotoh, Kazuhiro, Taketomi, Akinobu, Maehara, Yoshihiko, Nakashima, Manabu, Enjoji, Munechika

Volltext

Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver von Kohjima, Motoyuki, Yoshimoto, Tsuyoshi, Enjoji, Munechika, Fukushima, Nobuyoshi, Fukuizumi, Kunitaka, Nakamura, Tsukasa, Kurokawa, Miho, Fujimori, Nao, Sasaki, Yusuke, Shimonaka, Yasushi, Murata, Yusuke, Koyama, Susumu, Kawabe, Ken, Haraguchi, Kazuhiro, Sumida, Yorinobu, Harada, Naohiko, Kato, Masaki, Kotoh, Kazuhiro, Nakamuta, Makoto

Volltext

Add-on therapy of pitavastatin and eicosapentaenoic acid improves outcome of peginterferon plus ribavirin treatment for chronic hepatitis C von Kohjima, Motoyuki, Enjoji, Munechika, Yoshimoto, Tsuyoshi, Yada, Ryoko, Fujino, Tatsuya, Aoyagi, Yoko, Fukushima, Nobuyoshi, Fukuizumi, Kunitaka, Harada, Naohiko, Yada, Masayoshi, Kato, Masaki, Kotoh, Kazuhiro, Nakashima, Manabu, Sakamoto, Naoya, Tanaka, Yasuhito, Nakamuta, Makoto

Volltext

Acute liver failure caused by drug-induced hypersensitivity syndrome associated with hyperferritinemia von Miyazaki, Masayuki, Tanaka, Masatake, Ueda, Akihiro, Yoshimoto, Tsuyoshi, Kato, Masaki, Nakamuta, Makoto, Kotoh, Kazuhiro, Takayanagi, Ryoichi

Volltext

Arterial steroid injection therapy can inhibit the progression of severe acute hepatic failure toward fulminant liver failure von Kotoh, Kazuhiro, Enjoji, Munechika, Nakamuta, Makoto, Yoshimoto, Tsuyoshi, Kohjima, Motoyuki, Morizono, Shusuke, Yamashita, Shinsaku, Horikawa, Yuki, Yoshimitsu, Kengo, Tajima, Tsuyoshi, Asayama, Yoshiki, Ishigami, Kousei, Hirakawa, Masakazu

Volltext

Re-evaluation of antitumor effects of combination chemotherapy with interferon-α and 5-fluorouracil for advanced hepatocellular carcinoma von Enjoji, Munechika, Morizono, Shusuke, Kotoh, Kazuhiro, Kohjima, Motoyuki, Miyagi, Yuzuru, Yoshimoto, Tsuyoshi, Nakamuta, Makoto

Volltext

SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease von Kohjima, Motoyuki, Higuchi, Nobito, Kato, Masaki, Kotoh, Kazuhiro, Yoshimoto, Tsuyoshi, Fujino, Tatsuya, Yada, Masayoshi, Yada, Ryoko, Harada, Naohiko, Enjoji, Munechika, Takayanagi, Ryoichi, Nakamuta, Makoto

Volltext

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study von Sugimoto, Rie, Satoh, Takeaki, Ueda, Akihiro, Senju, Takeshi, Tanaka, Yuki, Yamashita, Shinsaku, Koyanagi, Toshimasa, Kurashige, Tomoyuki, Higuchi, Nobito, Nakamura, Tsukasa, Tanaka, Masatake, Azuma, Yuuki, Ohno, Akari, Ooho, Aritsune, Ooe, Mari, Mutsuki, Taiji, Uchimura, Koutarou, Kuniyoshi, Masami, Tada, Seiya, Aratake, Yoshifusa, Yoshimoto, Tsuyoshi, Yamashita, Naoki, Harada, Shigeru, Nakamuta, Makoto, Motomura, Kenta, Kohjima, Motoyuki

Volltext

Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol von Yasutake, Kenichiro, Nakamuta, Makoto, Shima, Yuki, Ohyama, Akiko, Masuda, Kaori, Haruta, Noriko, Fujino, Tatsuya, Aoyagi, Yoko, Fukuizumi, Kunitaka, Yoshimoto, Tsuyoshi, Takemoto, Ryosuke, Miyahara, Toshihiko, Harada, Naohiko, Hayata, Fukuko, Nakashima, Manabu, Enjoji, Munechika

Volltext

Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy von Fujino, Tatsuya, Aoyagi, Yoko, Takahashi, Mariko, Yada, Ryoko, Yamamoto, Naoko, Ohishi, Yuki, Nishiura, Akihiko, Kohjima, Motoyuki, Yoshimoto, Tsuyoshi, Fukuizumi, Kunitaka, Nakashima, Manabu, Kato, Masaki, Kotoh, Kazuhiro, Nakamuta, Makoto, Enjoji, Munechika

Volltext

An Adult Case with Hunters Syndrome Presenting Prominent Hepatic Failure: Light and Electron Microscopic Features of the Liver von Yoshimoto, Tsuyoshi, Nakamuta, Makoto, Kotoh, Kazuhiro, Kohjima, Motoyuki, Morizono, Shusuke, Miyagi, Yuzuru, Sakai, Hironori, Enjoji, Munechika

Volltext

Pathophysiological analysis of primary biliary cirrhosis focusing on choline/phospholipid metabolism von Kohjima, Motoyuki, Enjoji, Munechika, Yada, Ryoko, Yoshimoto, Tsuyoshi, Nakamura, Tsukasa, Fukuizumi, Kunitaka, Fukushima, Nobuyoshi, Murata, Yusuke, Nakashima, Manabu, Kato, Masaki, Kotoh, Kazuhiro, Shirabe, Ken, Maehara, Yoshihiko, Nakajima, Atsushi, Nozaki, Yuichi, Honda, Akira, Matsuzaki, Yasushi, Nakamuta, Makoto

Volltext

Impact of cholesterol metabolism and the LXRα-SREBP-1c pathway on nonalcoholic fatty liver disease von Nakamuta, Makoto, Fujino, Tatsuya, Yada, Ryoko, Yada, Masayoshi, Yasutake, Kenichiro, Yoshimoto, Tsuyoshi, Harada, Naohiko, Higuchi, Nobito, Kato, Masaki, Kohjima, Motoyuki, Taketomi, Akinobu, Maehara, Yoshihiko, Nakashima, Manabu, Kotoh, Kazuhiro, Enjoji, Munechika

Volltext

Sa1054 Add-on Lipid Modulators (Statin and EPA) for PEG-IFN and RBV Increases SVR Particularly in HCV Patients With Intractable IL-28B Rs8099917 Tg/GG Allele von Fukuizumi, Kunitaka, Kohjima, Motoyuki, Yoshimoto, Tsuyoshi, Fukushima, Nobuyoshi, Enjoji, Munechika, Nakamuta, Makoto

Volltext

Su1066 Cholesterol Metabolism During PEG-IFN + RBV + TVR Treatment von Nakamuta, Makoto, Kohjima, Motoyuki, Yoshimoto, Tsuyoshi, Nakamura, Tsukasa, Ohashi, Tomoko, Fukuizumi, Kunitaka, Fujimori, Nao, Kawabe, Ken, Haraguchi, Kazuhiro, Aso, Akira, Sumida, Yorinobu, Harada, Naohiko, Dohmen, Kazufumi, Nomura, Hideyuki, Enjoji, Munechika

Volltext

Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virusinfected liver von Motoyuki Kohjima Tsuyoshi Yoshimoto Munechika Enjoji Nobuyoshi Fukushima Kunitaka Fukuizumi Tsukasa Nakamura Miho Kurokawa Nao Fujimori Yusuke Sasaki Yasushi Shimonaka Yusuke Murata Susumu Koyama Ken Kawabe Kazuhiro Haraguchi Yorinobu Sumida Naohiko Harada Masaki Kato Kazuhiro Kotoh Makoto Nakamuta

Volltext